We are live on
!
Find out more
Regeneron Pharmaceuticals
REGN
REGN
1,177 hedge funds and large institutions have $75.1B invested in Regeneron Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 111 funds opening new positions, 401 increasing their positions, 446 reducing their positions, and 87 closing their positions.
New
Increased
Maintained
Reduced
Closed
28% more first-time investments, than exits
New positions opened: 111 | Existing positions closed: 87
13% more capital invested
Capital invested by funds: $66.2B → $75.1B (+$8.91B)
4% more funds holding in top 10
Funds holding in top 10: 28 → 29 (+1)
1% more funds holding
Funds holding: 1,165 → 1,177 (+12)
0.39% less ownership
Funds ownership: 85.84% → 85.45% (-0.39%)
10% less repeat investments, than reductions
Existing positions increased: 401 | Existing positions reduced: 446
11% less call options, than puts
Call options by funds: $1.43B | Put options by funds: $1.61B
Holders
1,177
Holders Change
+12
Holders Change %
+1.03%
% of All Funds
18.68%
Holding in Top 10
29
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+3.57%
% of All Funds
0.46%
New
111
Increased
401
Reduced
446
Closed
87
Calls
$1.43B
Puts
$1.61B
Net Calls
-$183M
Net Calls Change
+$45.7M
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$664M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$526M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$69.9M |
| 4 |
D.E. Shaw & Co
New York
|
+$64.9M |
| 5 |
ZIG
Zurich Insurance Group
Zurich,
Switzerland
|
+$62.3M |
Top Sellers
| 1 |
EWA
EP Wealth Advisors
Torrance,
California
|
-$446M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$348M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$248M |
| 4 |
BlackRock
New York
|
-$166M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$130M |
